Found 0 matching trials
A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis PHASE3 The primary objective of this study is to determine whether systemic chemot...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
HAIC Combined With Durvalumab, Tremelimumab and Bevacizumab as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma PHASE2 To evaluate the efficacy and safety of HAIC combined with Durvalumab, Treme...
Show More Location
Tianjin Cancer Hospital Airport Hospital
Learn More & Join Trial
Neoadjuvant Therapy (NALIRIFOX) for Locally Advanced Colon and Upper Rectal Cancer PHASE4 The goal of this clinical trial is to evaluating the efficacy and safety of...
Show More Status
Active Not Recruiting
Location
Cancer Hospital of Shantou University Medical College
Learn More & Join Trial
A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer PHASE3 This is a prospective, randomized Phase III trial of FLAC chemotherapy with...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
University of Arkansas for Medical Sciences
Learn More & Join Trial
Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis PHASE4 The investigators assessed whether the addition of a preoperative regimen o...
Show More Location
Department of Internal Medicine-Oncology
Learn More & Join Trial
FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma PHASE2 The purpose of the study is to assess the safety and efficacy of OncoSil™ w...
Show More Status
Active Not Recruiting
Location
Royal Adelaide Hospital
Learn More & Join Trial
Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma PHASE2 The purpose of this study is to characterize the safety, preliminary effica...
Show More Location
Lee Health/Regional Cancer Center
Learn More & Join Trial
Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer PHASE3 The goal of this Phase 3 clinical trial is to evaluate whether continuing c...
Show More Location
A.O.U. Ospedali Riuniti
Learn More & Join Trial
Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer PHASE2 Drugs used in chemotherapy, such as capecitabine and oxaliplatin, use diffe...
Show More Location
University of Texas
Learn More & Join Trial